|
J Biol Chem, Vol. 274, Issue 40, 28185-28190, October 1, 1999
Zebrafish Express the Common Parathyroid Hormone/Parathyroid
Hormone-related Peptide Receptor (PTH1R) and a Novel Receptor (PTH3R)
That Is Preferentially Activated by Mammalian and Fugufish Parathyroid
Hormone-related Peptide*
David A.
Rubin and
Harald
Jüppner§
From the Endocrine Unit and Pediatric Services, Massachusetts
General Hospital and Harvard Medical School,
Boston, Massachusetts 02114
 |
ABSTRACT |
To further explore the evolution of receptors for
parathyroid hormone (PTH) and PTH-related peptide (PTHrP), we
searched for zebrafish (z) homologs of the PTH/PTHrP receptor (PTH1R).
In mammalian genes encoding this receptor, exons M6/7 and M7 are highly
conserved and separated by 81-84 intronic nucleotides. Genomic
polymerase chain reaction using degenerate primers based on these exons
led to two distinct DNA fragments comprising portions of genes encoding the zPTH1R and the novel zPTH3R. Sequence comparison of both
full-length teleost receptors revealed 69% similarity (61% identity),
but less homology with zPTH2R. When compared with hPTH1R, zPTH1R showed 76% and zPTH3R 67% amino acid sequence similarity; similarity with
hPTH2R was only 59% for both teleost receptors. When expressed in
COS-7 cells, zPTH1R bound
[Tyr34]hPTH-(1-34)-amide (hPTH),
[Tyr36]hPTHrP-(1-36)-amide (hPTHrP), and
[Ala29,Glu30,Ala34,Glu35, Tyr36]fugufish
PTHrP-(1-36)-amide (fuguPTHrP) with a high apparent affinity
(IC50: 1.2-3.5 nM), and was efficiently
activated by all three peptides (EC50: 1.1-1.7
nM). In contrast, zPTH3R showed higher affinity for
fuguPTHrP and hPTHrP (IC50: 2.1-11.1 nM) than for hPTH (IC50: 118.2-127.0 nM); cAMP
accumulation was more efficiently stimulated by fugufish and human
PTHrP (EC50: 0.47 ± 0.27 and 0.45 ± 0.16, respectively) than by hPTH (EC50: 9.95 ± 1.5 nM). Agonist-stimulated total inositol phosphate
accumulation was observed with zPTH1R, but not zPTH3R.
 |
INTRODUCTION |
The parathyroid hormone
(PTH)1/PTH-related peptide
(PTHrP) receptor (PTH1R)2
mediates the actions of PTH and PTHrP in mammals and frogs (1, 2).
Despite their limited structural homology, which is restricted to the
amino-terminal region, both peptides bind with similar affinity to the
PTH1R and activate this common receptor with indistinguishable efficacy. Due to this unusual ligand specificity, the PTH1R mediates the PTH-dependent endocrine regulation of mineral ion
homeostasis (1, 2) and the PTHrP-dependent
autocrine/paracrine regulation of different developmental processes,
including mammary gland development and endochondral bone formation
(3-6).
There is considerable pharmacological evidence for other receptors with
specificity for amino-terminal PTH and PTHrP (1). For example,
Ca2+/inositol 1,4,5-trisphosphate-coupled PTH/PTHrP
receptors have been described for keratinocyte cultures, for squamous
cell carcinoma and insulinoma cell lines, and for cells from the
central nervous system (7-9). Other, more recent data indicate the
presence of a PTHrP-selective, cAMP-coupled receptor in the mammalian
supraoptic nucleus, which may be involved in the regulation of
vasopressin release (10, 11). Although these findings suggested the
presence of a distinct subfamily of PTH and/or PTHrP receptors, only
one novel cDNA encoding the PTH2 receptor (PTH2R) has been isolated thus far (12-14).
To explore the molecular evolution of PTH receptors, we previously
isolated DNAs encoding frog PTH1Rs (15) and teleost PTH2Rs (14). To
extend these studies, we now isolated DNAs that encode the zebrafish
homolog of the mammalian PTH1R and that of a novel, type 3 receptor
(PTH3R). As with the hPTH1R, human PTH (hPTH), fugufish PTHrP
(fuguPTHrP), and human PTHrP (hPTHrP) stimulated cAMP accumulation in
cells expressing the zebrafish PTH1R (zPTH1R). In contrast, the
zebrafish PTH3R (zPTH3R) was preferentially activated by fuguPTHrP and
hPTHrP, and less efficiently by hPTH. Furthermore, only the zPTH1R, but
not the zPTH3R, showed activation of the inositol 1,4,5-trisphosphate pathway.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Oligonucleotides and peptides were synthesized as
described (16) by the Massachusetts General Hospital Polymer Core
Facility. Zebrafish (Danio rerio) for DNA and RNA extraction
were purchased from a local aquarium. PCRs were performed on a MJ
Research Thermal Cycler (Watertown, MA) using 2.5-5 units of
Taq polymerase (Life Technologies, Inc.) or KlenTaq
(CLONTECH). Reverse transcription (RT) was
performed at 42 °C with Superscript II RNase H (Life
Technologies, Inc.). Restriction enzymes were from New England Biolabs
(Beverly, MA); T4 DNA ligase, pGEM-T, and pGEM-3Z from (Promega,
Madison, WI); DH5 E. coli cells from Life Technologies, Inc.; and Top 10 F' E. coli cells and pcDNAI/Amp from
Invitrogen. Plasmid DNA from single colonies was purified and sequenced
as described (14), and all nucleotide sequences were analyzed using the
GCG package (University of Wisconsin, Madison, WI).
Isolation of Genomic DNA Clones Encoding Portions of zPTH1R and
zPTH3R--
Degenerate forward (For) and reverse (Rev) primers were
based on known mammalian and frog PTH1R sequences (15), and are located
in regions corresponding to mammalian exons M6/7 and M7 (17) (Fig.
1A). PCRs using either For M6a
(5'-TTYGGIGTSCAYTAYATHGTVTT-3'; 576-fold degenerate) or For M6b
(5'-GTSYTBRTGCCICTHYTYGG-3'; 1152-fold degenerate), in combination with
Rev M7 (5'-CTCDCCATTRCAGWARCAGTADAT-3'; 72-fold degenerate), were
performed with 1 µg of zebrafish genomic DNA and the following
reaction profile: initial denaturation at 95 °C for 3 min,
denaturation at 94 °C for 1 min, annealing at 50 °C for 1 min,
and polymerization at 72 °C for 4 or 6 min; 35 cycles. Nested PCRs
were performed with 0.02 µl of the initial PCR product using Rev M7#2
(5'-GTADATRATDGMMACAAARAADCC-3'; 432-fold degenerate) (Fig.
1A), and either For M6a or For M6b using the same PCR
profile as before. DNA products of approximately 210 and 850 bp were
purified and ligated into pGEM-T to yield zPTH1R(TM6/7)/GEM-T and
zPTH3R(TM6/7)/GEM-T, respectively.
Isolation of Partial cDNA Clones Encoding zPTH1R and
zPTH3R--
RT-PCR using total RNA (5 µg) from adult zebrafish was
performed as described (14) with For and Rev primers that were based on
either zPTH1R or zPTH3R genomic DNA sequences (Fig. 1B). RT was performed with either zPTH1R/Rev 6(1)
(5'-GCATTTCATAATGCATCTGGATTTG-3') or zPTH3R/Rev 6(1)
(5'-CTGTGAAGAATTGAAGAGCATCTC-3'). Subsequent PCRs using For TM3
(5'-ACMAACTACTAYTGGATYCTGGTG-3'; 8-fold degenerate) and either
of the two Rev 6(1) primers was performed as described above,
except that annealing was at 56 °C (1 min) and polymerization at
72 °C for only 2 min. Subsequent nested PCRs were performed with
either zPTH1R/Rev 6(2) (5'-AGAAACTTCTGTGTAAGGCATCGC-3') or zPTH3R/Rev
6(2) (5'-AAGAGCCATGAACAGCATGTAATG-3'). PCR products of approximately
450 bp were cloned, as described above, into pGEM-T to yield
zPTH1R(TM3/6)/pGEMT and zPTH3R(TM3/6)/pGEMT, respectively.
Isolation of Full-length cDNAs Encoding the
zPTH1R--
Using a 5'-RACE kit (Life Technologies, Inc.) and total
zebrafish RNA, the 5' end of the cDNA encoding the zPTH1R was
amplified as described (14). zPTH1R Rev 6(2) was used for RT, and the first PCR was performed with the AUAP (Abridged
Universal Amplification Primer;
Life Technologies, Inc.) and Rev 6(3) (5'-GAAGACTATGTAGTGAACACCGAA-3') using the same PCR profile as above, except that annealing was at
55 °C (1 min) and that polymerization was at 72 °C (2 min) for
the first seven cycles, followed by 28 cycles with annealing at
64 °C. 0.05 µl of the resulting PCR product was reamplified, Rev
TM5 (5'-ATATTGTTGTCTGGTGTCACATCT-3') for the first nested PCR, and Rev
4x (5'-CGCATTTGTTTCTCGAAGTTTTGTTGC-3') for the second nested PCR.
The PCR profiles were identical, except for annealing at 62 °C for
1 min and polymerization at 72 °C for 2 min (35 cycles; final
extension 10 min at 72 °C). The products from the second nested PCR
were purified and ligated into pGEM-Teasy (Promega) to yield
zPTH1R(5')/pGEMTeasy.
RT for 3'-RACE was performed according to the manufacturer's
instructions using an oligo(dT)-containing adapter primer. PCR was
performed with For TM3 (5'-ATCTTCATGACCTTCTTCTCAGAC-3') and UAP
(Universal Adaptor Prime, Life
Technologies, Inc.), using the same profile as before, except annealing
at 64 °C for 1 min and polymerization at 72 °C for 3 min (35 cycles; final extension of 10 min at 72 °C). Nested PCR using For
4(1) (5'-AGGAAGTACCTCTGGGGCTTCA-3') and cloning of the resulting
products was performed as described above to yield
zPTH1R(3')/pGEMTeasy.
Midiprep DNA of zPTH1R(5')/pGEMTeasy and zPTH1R(3')/pGEMTeasy were
digested with MfeI and NdeI (New England Biolabs,
Beverly, MA). A 1.0-kilobase pair fragment from zPTH1R(3')/pGEMTeasy
was ligated into the corresponding sites of an approximately
4.5-kilobase pair fragment from zPTH1R(5')/pGEMTeasy to yield the
full-length zPTH1R clone, zPTH1R(FL)/pGEMTeasy. The
zPTH1R(FL)/pGEMTeasy plasmid DNA was digested with EcoRI
and SacI, and cloned into the corresponding sites in pGEM-3Z
(Promega) to yield zPTH1R(FL)/pGEM3Z. Subsequently, an
EcoRI/SphI fragment from zPTH1R(FL)/pGEM3Z was
cloned into pcDNAI/Amp to yield full-length
zPTH1R(FL)/pcDNAI/Amp (zPTH1R).
Isolation of Full-length cDNAs Encoding the zPTH3R--
A
zebrafish gt11 cDNA library (CLONTECH) was
screened by plaque hybridization using a 450-bp
32P-radiolabeled cDNA probe, generated by PCR from
zPTH3R(TM3/6)/pGEMT. Filters containing 1.5 × 106
plaque-forming units were hybridized as described (14); washes with 1×
SSC, 0.1% SDS for 30 min were at room temperature, 50 °C, and
55 °C, respectively. After autoradiography (5 days, 70 °C) with
intensifying screen (DuPont Cronex) and Kodak XAR film, a single phage
clone was plaque-purified and subcloned into the EcoRI site
of pcDNAI/Amp to yield zeb3-pcDNAI/Amp.
5'-RACE and 3'-RACE reactions (Life Technologies, Inc.) were performed
as above using three successive reverse zPTH3R-specific primers (TM1,
5'-GAAGAGGTGGATGTGGATGTAGTT-3'; G, 5['-GCAGTGGAGACGTTTGAAATA-3'; and
E3, 5'-CCAGTTACCTGATGCATCACAGTG-3'), and two successive forward primers (forZeb3 6(2), 5'-CAGATGCATTACGAGATGCTCTTC-3'; forZeb3-tail (2), 5'-TGGTTGCGAGCGAGTCTTGCGTTA-3'), respectively. The 5'- and
3'-RACE products were ligated to pGEMT-Easy to yield zeb3-5'/pGEMT and
zeb3-3'/pGEMT, respectively. A 240-bp
BamHI/ApaLI fragment from zeb3-5'/pGEMT was
subsequently ligated into the corresponding sites of
zeb3-pcDNAI/Amp to yield zeb3-5'zPTH3R/pcDNAI/Amp, and a
522-bp XhoI/SphI fragment from zeb3-3'/pGEMT was
ligated into the corresponding sites of zeb3-5-zPTH3R/pcDNAI/AMP
to yield the full-length clone (zPTH3R).
Transfection of COS-7 Cells, Radioreceptor Assays, and
Agonist-stimulated cAMP and IP Accumulation--
COS-7 African green
monkey kidney cells (approximately 200,000 cells/well) were cultured in
24-well plates and transfected with plasmid DNA encoding zPTH1R,
zPTH3R, or hPTH1R (200 ng/well) as described (14). After transfection,
cells were cultured for 72 h at 37 °C with daily exchanges of
medium, followed by an additional 24 h at 33 °C (16) until
functional evaluation after 96 h.
Radioreceptor assays with cells expressing either receptor were
performed as described (15) using 125I-labeled
[Nle8,Nle21,Tyr34]rPTH-(1-34)-amide
(rPTH) or 125I-labeled
[Tyr36]hPTHrP-(1-36)-amide (hPTHrP), and increasing
concentrations of either [Tyr34]hPTH-(1-34)-amide
(hPTH),
[Ala29,Glu30,Ala34,Glu35,Tyr36]fugufish
PTHrP-(1-36)-amide (fuguPTHrP), or hPTHrP. Specific binding was
calculated by subtracting radioligand binding in the presence of excess
unlabeled peptide from the total binding. All points represent
mean ± S.E. of two to three replicates from two or more
independent experiments. IC50 values (dose of a competing ligand that resulted in 50% inhibition of radioligand binding) were
calculated as described previously (16).
Intracellular accumulation of cAMP in the absence or presence of
different agonists was determined as described using transfected COS-7
cells (15, 16). To assess total IP accumulation, COS-7 cells
(approximately 800,000 cells/six-well plate) were transfected with
plasmid DNA (1 µg/well) encoding either zPTH1R, zPTH3R, or hPTH1R,
respectively (18, 19), and cultured for 3 days in DMEM, 7% fetal
bovine serum at 37 °C with daily exchanges of medium. The cells were
then preloaded with 3 µCi/ml
myo-[3H]inositol (NEN Life Science Products)
in inositol-free DMEM (Life Technologies, Inc.), 7% fetal bovine serum
(33 °C for 18 h). The following day, plates were rinsed and
then incubated with 10 6 M hPTH or hPTHrP in
DMEM, 0.1% bovine serum albumin, or with DMEM, 0.1% bovine serum
albumin alone (40 min at 37 °C), in the presence of 30 mM LiCl. Total IP was isolated by anion exchange column
chromatography as described previously (18, 19), and 1 ml of the eluate
(1/8th of total) was counted in a liquid scintillation counter (model
LS 6000IC; Beckman, Fullerton, CA). All points represent mean ± S.E. of two to three replicates from two or more independent experiments.
Southern Blot Analysis of Zebrafish Genomic
DNA--
Approximately 16 µg of zebrafish genomic DNA was digested
to completion with either BamHI, EcoRI, or
HindIII, split into two equal aliquots for electrophoresis
through a 0.8% agarose gel containing ethidium bromide, and
transferred onto a nitrocellulose membrane (MSI, Westborough, MA).
After baking in vacuo for 2 h at 80 °C, the blots
were hybridized in 50% formamide (42 °C for 18 h) with a
PCR-generated 32P-labeled probes (14) encoding either the
carboxyl-terminal tail of zPTH1R or zPTH3R (zPTH1R/tail and
zPTH3R/tail, 240 and 335 bp, respectively). Washes, for 30 min each,
were performed at room temperature and 42 °C in 1× SSC, 0.1% SDS,
and at 50 °C in 0.5× SSC, 0.1% SDS followed by autoradiography at
70 °C for 7 days with intensifying screen (DuPont Cronex) and
Kodak XAR film.
Phylogenetic and Structural Analyses of All Known
PTHRs--
Alignment of all known PTH1Rs, PTH2Rs, zebrafish PTH3R,
goldfish VIP receptor, and the human CRF receptor sequences was
performed as described previously (14). Sequences were subsequently
aligned within MacClade 3.0 (20), and gaps were entered to maximize the
homology of the native proteins. Each amino acid was treated as an
unweighted character when analyzed using the branch-and-bound search
option of PAUP 3.1 (21). A bootstrapping analysis using the heuristic
option on 250 replicates (22) was performed, and only groups that were
compatible with the 50% majority-rule consensus were retained (23).
Further analysis within MacClade was performed to determine residues
that are likely to be specific for each receptor subtype (14, 20).
 |
RESULTS AND DISCUSSION |
Isolation of Genomic DNAs Encoding Zebrafish PTH/PTHrP
Receptors--
Using zebrafish genomic DNA and several degenerate
forward and reverse primers (Fig.
1A), we obtained, under
relatively stringent conditions, two distinct products of approximately
200 and 840 bp. The 5' and 3' ends of these products showed significant
nucleotide sequence identity with each other (73%), with the hPTH1R
(78% and 73%, respectively), and with the hPTH2R (64% and 70%,
respectively), and are referred to as zPTH1R(TM6/7) and zPTH3R(TM6/7).
While zPTH1R(TM6/7) contained 84 bp of intronic sequence (compared with 81 bp of the hPTH1R) (24), zPTH3R(TM6/7) contained an intron of
approximately 750 bp. Taken together, the findings indicated that
portions of two distinct genes had been isolated which both share
higher homology with the PTH1R than with the PTH2R.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of exons M6/7 and M7
(panel A) and of the cDNAs encoding the
zPTH1R or zPTH3R (panel B).
Open boxes depict exons, and filled boxes depict transmembrane helices; approximate locations of
recognition sites for restriction enzymes are shown by
double vertical lines.
Arrows indicate the approximate location of primers used for
RT-PCR, 5'-RACE, and 3'-RACE. Primers in the tail region that are
receptor-specific were used to PCR-generate 32P-labeled
probes for the Southern analysis. Double-line arrows ( ),
degenerate primers; single line arrows with straight
heads, zPTH1R-specific; single line arrows with
curved heads, zPTH3R-specific; , conserved
sites for potential N-linked glycosylation.
|
|
Isolation of the cDNA Encoding the zPTH1R--
RT-PCR on total
zebrafish RNA using the For 3 and primers specific for zPTH1R(TM6/7)
(Fig. 1B) produced a 450-bp cDNA fragment, zPTH1R(TM3/6), which encodes a region corresponding to TM3 through TM6
of the mammalian PTH1R. Subsequently, 5'- and 3'-RACE reactions were
performed to generate overlapping sequences, and a full-length zPTH1R
clone was constructed using a unique MfeI restriction site. The amino acid sequence (536 residues) encoded by the full-length zPTH1R cDNA (Fig. 2) showed highest
sequence homology to the frog, fugufish, and mammalian PTH1Rs (15,
17).3 The overall amino acid
sequence homology with the hPTH1R was 76%, but only 68% when compared
with the hPTH2R, similar to the mammalian PTH1Rs (17, 24). The
3'-non-coding regions of zPTH1R and the zPTH3R did not contain typical
polyadenylation signals, but several imperfect sequences were found
upstream of the poly(A)n tails. 5'-RACE
generated two PCR products (5'-RACE#29, 149 bp; 5'-RACE#25, 391 bp), which contained an identical Kozak sequence and coding region
(including the putative signal sequence) but varied in the length of
the 5'-untranslated region.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 2.
Alignment of the amino acid sequences of the
zPTH1R, zPTH2R, and zPTH3R. Conserved consensus sites for
potential N-linked glycosylation are identified by #; 17 residues that are lacking in one splice variant of the zPTH2R are
boxed; the residues that are predicted to comprise the
signal peptide are outlined with a dotted box;
residues that appear to be PTH3R-specific are boxed. The
predicted locations of the transmembrane helices are
underlined.
|
|
Isolation of the cDNA Encoding a Novel PTHrP-selective Receptor
(PTH3R)--
Genomic clone zPTH3R(TM6/7) contained, at the 5' and 3'
end, nucleotide sequences that were similar to but distinct from zPTH1R and zPTH2R (14), and contained approximately 750 bp, rather than 84 bp,
of intronic sequence. This information indicated that portions of a
novel gene, subsequently referred to as zPTH3R, had been isolated.
RT-PCR using the For 3 and primers specific for zPTH3R(TM6/7) (Fig.
1B) produced a 450-bp cDNA clone, zPTH3R(TM3/6), which
encodes TM3 through TM6 of zPTH3R.
To isolate a full-length clone, we screened an adult zebrafish
phage cDNA library (1.5 × 106
plaque-forming units), and isolated a single clone that was subcloned to yield zeb3-3'/pcDNAI/Amp, and was shown to extend from the region corresponding to the mammalian exon E1 to the carboxyl-terminal region encoded by exon T (17, 24), but lacked the portions encoding the
amino-terminal, extracellular domain, and the termination codon
including the 3'-untranslated region. 3'-RACE on total zebrafish RNA
produced a single product that was subcloned into the
xhoI/sphI site of zeb3-3'/pcDNAI/Amp. 5'-RACE
using total zebrafish RNA revealed the presence of several putative
splice variants, which is similar to the findings with the zPTH1R (see
above) and the zPTH2R (14), and with several mammalian PTH1Rs (26-28).
Seven of 10 isolated zeb3-5' clones contained cDNA sequences that
were similar to the mammalian exons E1 and E3 (17, 24). These clones also contained a Kozak sequence and a nucleotide sequence with homology
to the signal peptide sequence found in the mammalian PTH1Rs (17, 24),
and were therefore ligated into the ApaLI site of
zeb3-3'/pcDNAI/ Amp to yield the full-length zPTH3R (see Fig.
1).
The remaining three zeb3-5' clones also contained the E1 and E3
equivalent, but differed at the 5' end and could therefore represent
putative splice variants. Similar to the zPTH2R (14) and the human
PTH1R (26, 28), one of these three putative splice variants of the
zPTH3R lacked a signal peptide sequence but did contain a potential
initiator AUG, which is located two codons upstream of the exon E1
equivalent. The second putative splice variant lacked a Kozak sequence,
an initiator AUG, and contained a charged sequence upstream of the
equivalent of E1, which is unlikely to represent a signal peptide.
Because of these structural features, both latter clones were not
characterized functionally.
Overall, the amino acid sequence comprising the full-length zPTH3R (542 residues, see Fig. 2) shared 69% similarity and 61% identity with
zPTH1R, but only 57% similarity and 48% identity with the zPTH2R
(14). Similar to the frog PTH1Rs (15) and all known PTH2Rs (12-14),
zPTH1R and zPTH3R lacked the equivalent of the cDNA encoded by exon
E2, suggesting that the appearance of this apparently non-essential
exon (29) represents a mammalian evolutionary innovation. In contrast
to this mammalian apomorphy regarding exon E2, zPTH1R and zPTH3R
contained numerous "signature residues" that are characteristic of
this family of G protein-coupled receptors; only two consensus
sequences for potential N-linked glycosylation were found to
be conserved for all zebrafish PTH receptors (see Fig. 2). Amino acid
sequence comparisons of the intracellular carboxyl-terminal tails
showed that zPTH1R and hPTH1R share 56% similarity, which is similar
to the 58% similarity between zPTH2R and hPTH2R (Table
I). In contrast, the amino acid sequence homology between the tail regions of zPTH3R and hPTH1R is only 38%,
and only 32% when compared with hPTH2R. The zPTH3R was therefore identified as a novel member within the PTH/PTHrP receptor family.
View this table:
[in this window]
[in a new window]
|
Table I
Amino acid sequence comparisons
Table shows comparisons of the amino acid sequences of the
intracellular, carboxy-terminal tail of different PTH receptors.
Residues comprising the tail region of the zPTH1R and zPTH3R were
compared to corresponding regions of the zPTH2R, and the human PTH1R or
PTH2R.
|
|
Functional Characterization of zPTH1R and zPTH3R--
COS-7 cells
expressing either zPTH1R#25 or zPTH1R#29 showed almost
indistinguishable results with regard to binding of either radioligand,
and with regard to agonist-stimulated cAMP and IP accumulation;
therefore, only results obtained with zPTH1R#29 are presented in
detail, and referred to as zPTH1R.
COS-7 cells expressing zPTH1R, zPTH3R, or hPTH1R showed similar basal
cAMP accumulation (4.3 ± 0.8, 7.2 ± 1.1, and 8.4 ± 1.9 pmol/well, respectively). Significant differences were observed with regard to maximal agonist-stimulated cAMP accumulation (91.5 ± 8.0, 229.6 ± 26.7, and 357.7 ± 30.5 pmol/well), but all
three peptides, hPTH, hPTHrP, and fuguPTHrP, showed indistinguishable efficacies with either receptor.
The zPTH3R was most efficiently activated by hPTHrP and
fuguPTHrP, while hPTH was approximately
22-fold less potent (Fig. 3A, Table
II). Interestingly, the zPTH3R showed
significant activation already at 10 11 M
human or fugufish PTHrP. In contrast, the zPTH1R was activated with
similar efficacy by hPTH, hPTHrP, and fuguPTHrP (Fig. 3B, Table II), and fuguPTHrP was less potent than hPTH or hPTHrP when tested with the hPTH1R (Fig. 3C, Table II). These findings
indicated that the zPTH3R interacts preferentially with PTHrP, while
the zPTH1R showed characteristics that are similar to those of the human receptor homolog. FuguPTHrP, which shares more amino acid sequence homology with hPTHrP than with hPTH, was surprisingly active
when tested with either zebrafish or human receptors, indicating that
its functional characteristics have been preserved throughout evolution.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Agonist-induced cAMP accumulation. COS-7
cells transiently expressing zPTH3R (A), zPTH1R
(B), or hPTH1R (C) were evaluated for
agonist-stimulated cAMP production ( , hPTH; , hPTHrP; ,
fuguPTHrP). Data are expressed as percentage of maximal cAMP
accumulation, and represent the mean ± S.E. of at least three
independent transfections.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Binding and signaling properties of the zPTH1R and zPTH3R
Radioreceptor studies using 125I-labeled hPTHrP or rPTH, and
cAMP accumulation assays were performed as described under
"Experimental Procedures." EC50 and IC50 values
represent the mean ± S.E. of at least three independent
transfections.
|
|
Consistent with the above findings, i.e. higher efficiency
of cAMP accumulation, cells expressing the zPTH3R showed higher specific binding of radiolabeled hPTHrP than of rPTH (20.6 ± 0.6% and 13.3 ± 1.38%, respectively). Furthermore, regardless
of the tracer that was used for radioreceptor experiments, apparent
binding affinities were higher for fuguPTHrP and hPTHrP, than for hPTH (Fig. 4, A and C,
Table II). In contrast, cells expressing the zPTH1R showed,
irrespective of the radioligand, similar apparent binding affinities
for fuguPTHrP, hPTHrP, and hPTH (Fig. 4, B and D,
Table II). Consistent with the less efficient activation of the hPTH1R
by fuguPTHrP, the human receptor homolog showed an approximately 2-fold
lower apparent binding affinity for the teleost analog, than for
mammalian PTH and PTHrP (data not shown). These findings confirmed that
the novel zPTH3R interacts preferentially with PTHrP, while the zPTH1R
and the hPTH1R interact almost equivalently with all three tested
peptides.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 4.
Radioreceptor studies. COS-7 cells
transiently expressing the zPTH3R (A, C) or
zPTH1R (B, D) were incubated with either
125I-[Tyr36]hPTHrP-(1-36)-amide
(A, B) or
125I-[Nle8,21,Tyr34]rPTH-(1-34)-amide
(C, D) and increasing concentrations of unlabeled
peptide ( , hPTH; , hPTHrP; , fuguPTHrP). Data are expressed as
percentage of maximal specific binding, and represent the mean ± S.E. of at least three independent transfections.
|
|
Comparable to the mammalian PTH1Rs, COS-7 cells expressing the zPTH1R
showed an equivalent increase of IP accumulation (2-fold) when
stimulated with either hPTH or hPTHrP. In contrast, despite higher
expression levels, no IP accumulation was detectable when cells
expressing zPTH3R were challenged with either ligand (Fig. 5). It remains to be determined which
portion(s) in the zPTH3R confer this alteration in signaling, and
whether any of the amino acid residues that were previously identified
in the rat PTH1R as being important for IP signaling could provide an
explanation for the differences in phospholipase C activation (19).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 5.
Accumulation of total IP in COS-7 cells
transiently expressing the hPTH1R, zPTH1R, or the zPTH3R.
Hydrolysis of total IPs was assessed as described in the absence or
presence of hPTH (10 6 M) or hPTHrP
(10 6 M). Data are expressed as -fold above
basal and represent the mean ± S.E. of two independent
experiments.
|
|
Southern Blot Analysis Using cDNA Probes That Are Specific for
the zPTH1R or the zPTH3R--
To confirm that zPTH1R and zPTH3R are
encoded by distinct genes, three infrequently cutting restriction
endonucleases were utilized to digest zebrafish genomic DNA to
completion (Fig. 6). Initial Southern
blot data using probes corresponding to TM3 through TM6 of either
receptor showed multiple hybridizing DNA species, indicating that these
probes cross-hybridized with each other's gene or with closely related
genes (data not shown). To increase the specificity for either subtype,
hybridizations were performed with radiolabeled probes comprising only
the tail region of each receptor, zPTH1R/tail or zPTH3R/tail, which
showed the highest rates of sequence variation between PTH receptor
subtypes. For each digest the tail probes hybridized, under stringent
conditions, to single but different genomic DNA fragments, indicating
that distinct genes encode zPTH1R and zPTH3R.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 6.
Southern blot hybridization of zebrafish
genomic DNA (see "Experimental Procedures"). Blots were
hybridized with probes encoding the intracellular, carboxyl-terminal
tail of zPTH1R or zPTH3R.
|
|
Phylogenetic and Structural Analyses of the zPTH1R and the
zPTH3R--
The single most parsimonious Bootstrap consensus tree
revealed two clades, the PTH2R clade and the PTH1R/PTH3R clade. Within the PTH1R/PTH3R clade, the PTH3R grouped in a significantly different manner from the PTH1Rs, and the terminal branches for the latter group
were found to be congruent with morphology-based phylogenies (25) (Fig.
7). Although additional data are
required, multivariate analysis suggested that some amino acid residues
are PTH3R-specific, and some of these could explain the functional
differences for both receptors, particularly with regard to
phospholipase C activation.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
A phylogenetic analysis, as described under
"Experimental Procedures," indicated that the single
most parsimonious tree had a length of 1594 steps, and a consistency
index excluding uninformative characters of 0.85. The bootstrap
confidence intervals are shown next to the branch points and indicate
the percentage of trials that support a given branch in 100 heuristic
iterations.
|
|
In summary, two cDNAs were isolated, which encode related but
distinct PTHRs. Despite the considerable phylogenetic distance between
teleosts and mammals, the PTH1Rs from these divergent species were
found to be sufficiently alike to allow an equivalent interaction with
mammalian G proteins, and efficient activation by PTH and PTHrP
analogs. PTH1R and PTH2R from all known species thus appear to have
similar structural and functional properties, making it likely that the
mammalian homolog of the zPTH3R will show a similar ligand selectivity
as the teleost receptor.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Ernestina Schipani, Kenneth B. Jonsson, Thomas J. Gardella, Henry T. Keutmann, Henry M. Kronenberg,
and John T. Potts, Jr. for their suggestions and comments.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
National Research Service Award F32 DK09500 (to D. A. R.) and
National Institutes of Health Grant DK-11794.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of National Research Service Award DK09500.
§
To whom correspondence should be addressed. E-mail:
jueppner@helix.mgh.harvard.edu.
2
GenBank accession numbers for PTH1Rs are
as follows: rat, M77184; mouse, X78936; human, X68596; pig, U18315;
opossum, M74445; Xenopus A, 1204422; Xenopus B,
1209822; zebrafish, AF132084; fugufish, 022I03aA12, 020N20aG6,
002B12aB11, 002B12aB12, and 002B12aC12. GenBank accession numbers for
PTH2Rs are as follows: catfish, AF132081; zebrafish, AF32082; rat
PTH2R, U55836; human PTH2R, U25128. zebrafish PTH3R, AF132085; goldfish VIPR, U56391; human CRFR-A, P34998.
3
Fugufish data were obtained from the Fugufish
Mapping Project (Medical Research Council, United Kingdom).
 |
ABBREVIATIONS |
The abbreviations used are:
PTH, parathyroid hormone;
PTHrP, PTH-related peptide;
PTH1R, PTH/PTHrP
receptor;
PTH2R, PTH2 receptor;
PTH3R, PTH3 receptor;
DMEM, Dulbecco's
modified Eagle's medium;
hPTH, [Tyr34]hPTH-(1-34)-amide;
hPTHrP, [Tyr36]hPTHrP-(1-36)-amide;
fuguPTHrP, [Ala29,Glu30,Ala34,Glu35,Tyr36]fugufish
PTHrP-(1-36)-amide;
bp, base pair(s);
PCR, polymerase chain reaction;
RT, reverse transcriptase;
TM, transmembrane domain;
IP, inositol
phosphate;
RACE, rapid amplification of cDNA ends.
 |
REFERENCES |
| 1.
|
Potts, J. T., Jr.,
and Jüppner, H.
(1997)
in
Metabolic Bone Disease
(Avioli, L. V.
, and Krane, S. M., eds), 3rd Ed.
, pp. 51-94, Academic Press, New York
|
| 2.
|
Broadus, A. E.,
and Stewart, A. F.
(1994)
in
The Parathyroids: Basic and Clinical Concepts
(Bilezikian, J. P.
, Levine, M. A.
, and Marcus, R., eds)
, pp. 259-294, Raven Press, New York
|
| 3.
|
Lanske, B.,
Karaplis, A. C.,
Luz, A.,
Vortkamp, A.,
Pirro, A.,
Karperien, M.,
Defize, L. H. K.,
Ho, C.,
Mulligan, R. C.,
Abou-Samra, A. B.,
Jüppner, H.,
Segre, G. V.,
and Kronenberg, H. M.
(1996)
Science
273,
663-666[Abstract]
|
| 4.
|
Karaplis, A. C.,
Luz, A.,
Glowacki, J.,
Bronson, R.,
Tybulewicz, V.,
Kronenberg, H. M.,
and Mulligan, R. C.
(1994)
Genes Dev.
8,
277-289[Abstract/Free Full Text]
|
| 5.
|
Wysolmerski, J.,
Philbrick, W.,
Dunbar, M.,
Lanske, B.,
Kronenberg, H.,
and Broadus, A.
(1998)
Development
125,
1285-1294[Abstract]
|
| 6.
|
Philbrick, W. M.,
Dreyer, B. E.,
Nakchbandi, I. A.,
and Karaplis, A. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11846-11851[Abstract/Free Full Text]
|
| 7.
|
Orloff, J. J.,
Ganz, M. B.,
Ribaudo, A. E.,
Burtis, W. J.,
Reiss, M.,
Milstone, L. M.,
and Stewart, A. F.
(1992)
Am. J. Physiol.
262,
E599-E607[Abstract/Free Full Text]
|
| 8.
|
Gaich, G.,
Orloff, J. J.,
Atillasoy, E. J.,
Burtis, W. J.,
Ganz, M. B.,
and Stewart, A. F.
(1993)
Endocrinology
132,
1402-1409[Abstract/Free Full Text]
|
| 9.
|
Fukayama, S.,
Tashjian, A. H., Jr.,
Davis, J. N.,
and Chisolm, J. C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10182-10886[Abstract/Free Full Text]
|
| 10.
|
Yamamoto, S.,
Morimoto, I.,
Yanagihara, N.,
Zeki, K.,
Fujihira, T.,
Izumi, F.,
Yamashita, H.,
and Eto, S.
(1997)
Endocrinology
138,
2066-2072[Abstract/Free Full Text]
|
| 11.
|
Yamamoto, S.,
Morimoto, I.,
Zeki, K.,
Ueta, Y.,
Yamashita, H.,
Kannan, H.,
and Eto, S.
(1998)
Endocrinology
139,
383-388[Abstract/Free Full Text]
|
| 12.
|
Usdin, T. B.,
Gruber, C.,
and Bonner, T. I.
(1995)
J. Biol. Chem.
270,
15455-15458[Abstract/Free Full Text]
|
| 13.
|
Usdin, T. B.,
Bonner, T. I.,
Harta, G.,
and Mezey, E.
(1996)
Endocrinology
137,
4285-4297[Abstract]
|
| 14.
|
Rubin, D. A.,
Hellman, P.,
Zon, L. I.,
Lobb, C. J.,
Bergwitz, C.,
and Jüppner, H.
(1999)
J. Biol. Chem.
274,
23035-23042[Abstract/Free Full Text]
|
| 15.
|
Bergwitz, C.,
Klein, P.,
Kohno, H.,
Forman, S. A.,
Lee, K.,
Rubin, D.,
and Jüppner, H.
(1998)
Endocrinology
139,
723-732[Abstract/Free Full Text]
|
| 16.
|
Gardella, T. J.,
Luck, M. D.,
Jensen, G. S.,
Usdin, T. B.,
and Jüppner, H.
(1996)
J. Biol. Chem.
271,
19888-19893[Abstract/Free Full Text]
|
| 17.
|
Kong, X. F.,
Schipani, E.,
Lanske, B.,
Joun, H.,
Karperien, M.,
Defize, L. H. K.,
Jüppner, H.,
Potts, J. T.,
Segre, G. V.,
Kronenberg, H. M.,
and Abou-Samra, A. B.
(1994)
Biochem. Biophys. Res. Commun.
200,
1290-1299[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Iida-Klein, A.,
Guo, J.,
Drake, M. T.,
Kronenberg, H. M.,
Abou-Samra, A. B.,
Bringhurst, F. R.,
and Segre, G. V.
(1995)
Miner. Electrolyte Metab.
21,
177-179[Medline]
[Order article via Infotrieve]
|
| 19.
|
Iida-Klein, A.,
Guo, J.,
Takamura, M.,
Drake, M.,
Potts, J. T., Jr.,
Abou-Samra, A. B.,
Bringhurst, F. R.,
and Segre, G. V.
(1997)
J. Biol. Chem.
272,
6882-6889[Abstract/Free Full Text]
|
| 20.
|
Maddison, W. P.,
and Maddison, M. D.
(1992)
MacClade
, 3rd Ed.
, Sinauer Associates, Inc., Sunderland, MA
|
| 21.
|
Swofford, D. L.
(1993)
PAUP: Phylogenetic Analysis Using Parsimony, 3.1 Ed.
, Illinois Natural History Survey, Champaign, IL
|
| 22.
|
Hedges, S. B.
(1992)
Mol. Biol. Evol.
9,
366-369[Medline]
[Order article via Infotrieve]
|
| 23.
|
Swofford, D. L.,
and Olsen, G. J.
(1990)
in
Molecular Systematics
(Hillis, D. M.
, and Moritz, C., eds)
, pp. 411-501, Sinauer Associates, Inc., Sunderland, MA
|
| 24.
|
Schipani, E.,
Weinstein, L. S.,
Bergwitz, C.,
Iida-Klein, A.,
Kong, X. F.,
Stuhrmann, M.,
Kruse, K.,
Whyte, M. P.,
Murray, T.,
Schmidtke, J.,
van Dop, C.,
Brickman, A. S.,
Crawford, J. D.,
Potts, J. T., Jr.,
Kronenberg, H. M.,
Abou-Samra, A. B.,
Segre, G. V.,
and Jüppner, H.
(1995)
J. Clin. Endocrinol. Metab.
80,
1611-1621[Abstract/Free Full Text]
|
| 25.
|
Pough, F. H.,
Heiser, J. B.,
and McFarland, W. N.
(1989)
Vertebrate Life
, 3rd Ed.
, Macmillan, New York
|
| 26.
|
Joun, H.,
Lanske, B.,
Karperien, M.,
Qian, F.,
Defize, L.,
and Abou-Samra, A.
(1997)
Endocrinology
138,
1742-1749[Abstract/Free Full Text]
|
| 27.
|
Jobert, A. S.,
Fernandes, I.,
Turner, G.,
Coureau, C.,
Prie, D.,
Nissenson, R. A.,
Friedlander, G.,
and Silve, C.
(1996)
Mol. Endocrinol.
10,
1066-1076[Abstract/Free Full Text]
|
| 28.
|
Bettoun, J. D.,
Minagawa, M.,
Hendy, G. N.,
Alpert, L. C.,
Goodyer, C. G.,
Goltzman, D.,
and White, J. H.
(1998)
J. Clin. Invest.
102,
958-967[Medline]
[Order article via Infotrieve]
|
| 29.
|
Lee, C.,
Gardella, T. J.,
Abou-Samra, A. B.,
Nussbaum, S. R.,
Segre, G. V.,
Potts, J. T., Jr.,
Kronenberg, H. M.,
and Jüppner, H.
(1994)
Endocrinology
135,
1488-1495[Abstract]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W Abbink, X M Hang, P M Guerreiro, F A T Spanings, H A Ross, A V M Canario, and G Flik
Parathyroid hormone-related protein and calcium regulation in vitamin D-deficient sea bream (Sparus auratus)
J. Endocrinol.,
June 1, 2007;
193(3):
473 - 480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Guerreiro, J. L. Renfro, D. M. Power, and A. V. M. Canario
The parathyroid hormone family of peptides: structure, tissue distribution, regulation, and potential functional roles in calcium and phosphate balance in fish
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2007;
292(2):
R679 - R696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fuentes, J. Figueiredo, D. M. Power, and A. V. M. Canario
Parathyroid hormone-related protein regulates intestinal calcium transport in sea bream (Sparus auratus)
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2006;
291(5):
R1499 - R1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Abbink, G. S. Bevelander, X. Hang, W. Lu, P. M. Guerreiro, T. Spanings, A. V. M. Canario, and G. Flik
PTHrP regulation and calcium balance in sea bream (Sparus auratus L.) under calcium constraint
J. Exp. Biol.,
September 15, 2006;
209(18):
3550 - 3557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fleming, M. Sato, and P. Goldsmith
High-Throughput In Vivo Screening for Bone Anabolic Compounds with Zebrafish
J Biomol Screen,
December 1, 2005;
10(8):
823 - 831.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gensure and H. Juppner
Parathyroid Hormone without Parathyroid Glands
Endocrinology,
February 1, 2005;
146(2):
544 - 546.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Hogan, J. A. Danks, J. E. Layton, N. E. Hall, J. K. Heath, and G. J. Lieschke
Duplicate Zebrafish pth Genes Are Expressed along the Lateral Line and in the Central Nervous System during Embryogenesis
Endocrinology,
February 1, 2005;
146(2):
547 - 551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Evans, P. M. Piermarini, and K. P. Choe
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
Physiol Rev,
January 1, 2005;
85(1):
97 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rotllant, P. M. Guerreiro, L. Anjos, B. Redruello, A. V. M. Canario, and D. M. Power
Stimulation of Cortisol Release by the N Terminus of Teleost Parathyroid Hormone-Related Protein in Interrenal Cells in Vitro
Endocrinology,
January 1, 2005;
146(1):
71 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Papasani, R. C. Gensure, Y.-L. Yan, Y. Gunes, J. H. Postlethwait, B. Ponugoti, M. R. John, H. Juppner, and D. A. Rubin
Identification and Characterization of the Zebrafish and Fugu Genes Encoding Tuberoinfundibular Peptide 39
Endocrinology,
November 1, 2004;
145(11):
5294 - 5304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Gensure, B. Ponugoti, Y. Gunes, M. R. Papasani, B. Lanske, M. Bastepe, D. A. Rubin, and H. Juppner
Identification and Characterization of Two Parathyroid Hormone-Like Molecules in Zebrafish
Endocrinology,
April 1, 2004;
145(4):
1634 - 1639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sugimura, T. Murase, S. Ishizaki, K. Tachikawa, H. Arima, Y. Miura, T. B. Usdin, and Y. Oiso
Centrally Administered Tuberoinfundibular Peptide of 39 Residues Inhibits Arginine Vasopressin Release in Conscious Rats
Endocrinology,
July 1, 2003;
144(7):
2791 - 2796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Spitsbergen and M. L. Kent
The State of the Art of the Zebrafish Model for Toxicology and Toxicologic Pathology Research--Advantages and Current Limitations
Toxicol Pathol,
January 1, 2003;
31(1_suppl):
62 - 87.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Goodman, I. B. Salusky, and H. Juppner
New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments
Nephrol. Dial. Transplant.,
October 1, 2002;
17(10):
1731 - 1736.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Guerreiro, J. Fuentes, D. M. Power, P. M. Ingleton, G. Flik, and A. V. M. Canario
Parathyroid hormone-related protein: a calcium regulatory factor in sea bream (Sparus aurata L.) larvae
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2001;
281(3):
R855 - R860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Ward, C. J. Small, K. G. Murphy, A. R. Kennedy, M. A. Ghatei, and S. R. Bloom
The Actions of Tuberoinfundibular Peptide on the Hypothalamo-Pituitary Axes
Endocrinology,
August 1, 2001;
142(8):
3451 - 3456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mizuno, N. Ono, and T. Ohhashi
Parathyroid hormone-related protein-(1-34) inhibits intrinsic pump activity of isolated murine lymph vessels
Am J Physiol Heart Circ Physiol,
July 1, 2001;
281(1):
H60 - H66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. J. Hoare, D. A. Rubin, H. Juppner, and T. B. Usdin
Evaluating the Ligand Specificity of Zebrafish Parathyroid Hormone (PTH) Receptors: Comparison of PTH, PTH-Related Protein, and Tuberoinfundibular Peptide of 39 Residues
Endocrinology,
September 1, 2000;
141(9):
3080 - 3086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Gensure, T. J. Gardella, and H. Juppner
Multiple Sites of Contact between the Carboxyl-terminal Binding Domain of PTHrP-(1-36) Analogs and the Amino-terminal Extracellular Domain of the PTH/PTHrP Receptor Identified by Photoaffinity Cross-linking
J. Biol. Chem.,
July 27, 2001;
276(31):
28650 - 28658.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|